APOTHEEK JOHAN COPPENS: what changed
APOTHEEK JOHAN COPPENS
Largest movements
- Receivables within one year +€29,958
up €29,958 (+172%), from €17,394 to €47,352
of which Trade receivables: +€30,305
- Current investments +€25,163
new in 2025: €25,163
- Cash -€9,442
down €9,442 (-22.7%), from €41,644 to €32,202
mainly Net result for the year (-€41,755) and Receivables within one year (-€29,958)
- Deferred charges and accrued income +€5,958
up €5,958 (+18.7%), from €31,868 to €37,826
- Stocks and contracts +€4,587
up €4,587 (+5.3%), from €85,834 to €90,421
- Other debts +€90,135
up €90,135 (+150%), from €59,998 to €150,133
- Profit (loss) carried forward -€41,755
down €41,755 (-158%), from -€26,492 to -€68,247
- Tax, wage and social debts +€6,593
up €6,593 (+72.9%), from €9,040 to €15,633
of which Remuneration and social security: +€6,196
- Staff costs +€39,046
up €39,046 (+50.5%), from €77,369 to €116,415
- Gross operating margin +€22,463
up €22,463 (+37.0%), from €60,747 to €83,211
- Depreciation -€931
down €931 (-13.0%), from €7,172 to €6,241
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €192,972 | €248,919 | +€55,947 | +29.0% |
| Fixed assets | 21/28 | €16,232 | €15,955 | -€277 | -1.7% |
| Tangible fixed assets | 22/27 | €16,232 | €15,955 | -€277 | -1.7% |
| Plant, machinery and equipment | 23 | €10,079 | €6,289 | -€3,790 | -37.6% |
| Furniture and vehicles | 24 | - | €5,367 | +€5,367 | |
| Other tangible fixed assets | 26 | €6,153 | €4,298 | -€1,855 | -30.1% |
| Current assets | 29/58 | €176,740 | €232,964 | +€56,224 | +31.8% |
| Stocks and contracts in progress | 3 | €85,834 | €90,421 | +€4,587 | +5.3% |
| Stocks | 30/36 | €85,834 | €90,421 | +€4,587 | +5.3% |
| Amounts receivable within one year | 40/41 | €17,394 | €47,352 | +€29,958 | +172% |
| Trade receivables | 40 | €13,663 | €43,968 | +€30,305 | +222% |
| Other amounts receivable | 41 | €3,731 | €3,384 | -€347 | -9.3% |
| Current investments | 50/53 | - | €25,163 | +€25,163 | |
| Cash at bank and in hand | 54/58 | €41,644 | €32,202 | -€9,442 | -22.7% |
| Deferred charges and accrued income | 490/1 | €31,868 | €37,826 | +€5,958 | +18.7% |
| Total equity and liabilities | 10/49 | €192,972 | €248,919 | +€55,947 | +29.0% |
| Equity | 10/15 | €52,430 | €10,675 | -€41,755 | -79.6% |
| Contributions | 10/11 | €78,000 | €78,000 | = | 0.0% |
| Reserves | 13 | €922 | €922 | = | 0.0% |
| Tax-exempt reserves | 132 | €63 | €63 | = | 0.0% |
| Distributable reserves | 133 | €859 | €859 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€26,492 | -€68,247 | -€41,755 | -158% |
| Amounts payable | 17/49 | €140,542 | €238,244 | +€97,702 | +69.5% |
| Amounts payable after more than one year | 17 | €10,000 | €10,000 | = | 0.0% |
| Financial debts | 170/4 | €10,000 | €10,000 | = | 0.0% |
| Amounts payable within one year | 42/48 | €128,003 | €225,858 | +€97,855 | +76.4% |
| Trade debts | 44 | €58,965 | €60,092 | +€1,127 | +1.9% |
| Suppliers | 440/4 | €58,965 | €60,092 | +€1,127 | +1.9% |
| Taxes, remuneration and social security | 45 | €9,040 | €15,633 | +€6,593 | +72.9% |
| Taxes | 450/3 | €1,431 | €1,828 | +€397 | +27.7% |
| Remuneration and social security | 454/9 | €7,609 | €13,805 | +€6,196 | +81.4% |
| Other amounts payable | 47/48 | €59,998 | €150,133 | +€90,135 | +150% |
| Accrued charges and deferred income | 492/3 | €2,539 | €2,386 | -€153 | -6.0% |
| Remuneration, social security and pensions | 62 | €77,369 | €116,415 | +€39,046 | +50.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €7,172 | €6,241 | -€931 | -13.0% |
| Other operating charges | 640/8 | €2,474 | €2,647 | +€173 | +7.0% |
| Gross operating margin | 9900 | €60,747 | €83,211 | +€22,463 | +37.0% |
| Operating profit (loss) | 9901 | -€26,268 | -€42,092 | -€15,824 | -60.2% |
| Financial income | 75/76B | €963 | €712 | -€251 | -26.1% |
| Recurring financial income | 75 | €963 | €712 | -€251 | -26.1% |
| Financial charges | 65/66B | €233 | €211 | -€22 | -9.3% |
| Recurring financial charges | 65 | €233 | €211 | -€22 | -9.3% |
| Profit (loss) for the period before taxes | 9903 | -€25,537 | -€41,591 | -€16,054 | -62.9% |
| Income taxes | 67/77 | €159 | €164 | +€5 | +3.2% |
| Profit (loss) for the period | 9904 | -€25,696 | -€41,755 | -€16,059 | -62.5% |
| Profit (loss) for the period to be appropriated | 9905 | -€25,696 | -€41,755 | -€16,059 | -62.5% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 5 November 2026 via checked.be.